{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:09:33Z","timestamp":1791256173747,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90156-3","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:46:09Z","timestamp":1742582769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Synthesis, in vitro, and in silico studies of 7-fluorochromone based thiosemicarbazones as \u03b1-glucosidase inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Faiqa","family":"Noreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj N.","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Albekairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul D.","family":"Jawarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"90156_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22170","volume":"85","author":"Y Ke","year":"2024","unstructured":"Ke, Y. et al. Xanthones with multiple roles against diabetes: their synthesis, structure-activity relationship, and mechanism studies. Drug Dev. Res. 85, e22170 (2024).","journal-title":"Drug Dev. Res."},{"key":"90156_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.4811","author":"SGD Feitosa","year":"2024","unstructured":"Feitosa, S. G. D., Lins, I. M. S., dos Maciel, L. G. & Anjos, J. V. Discovery of novel heterocyclic derivatives containing oxadiazolone or pyrimidinone cores as DPP-4 inhibitors. J. Heterocycl. Chem. https:\/\/doi.org\/10.1002\/jhet.4811 (2024).","journal-title":"J. Heterocycl. Chem."},{"key":"90156_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"90156_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137374","volume":"1301","author":"EA Fayed","year":"2024","unstructured":"Fayed, E. A., Thabet, A., Abd El-Gilil, S. M., Elsanhory, H. M. & Ammar, Y. A. Fluorinated thiazole\u2013thiosemicarbazones hybrids as potential PPAR-\u03b3 agonist and \u03b1-amylase, \u03b1-glucosidase antagonists: Design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation. J. Mol. Struct. 1301, 137374 (2024).","journal-title":"J. Mol. Struct."},{"key":"90156_CR5","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1038\/s41598-024-54563-2","volume":"14","author":"M Wahidin","year":"2024","unstructured":"Wahidin, M. et al. Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs. Sci. Rep. 14, 5424 (2024).","journal-title":"Sci. Rep."},{"key":"90156_CR6","first-page":"838","volume":"9","author":"R Kumar","year":"2020","unstructured":"Kumar, R. et al. A review on diabetes mellitus: type1 & Type2. World J. Pharm. & Pharmaceutical Sci. 9, 838\u2013850 (2020).","journal-title":"World J. Pharm. & Pharmaceutical Sci."},{"key":"90156_CR7","doi-asserted-by":"crossref","unstructured":"Jadon, A. S. et al. In Biochemical Immunology of Diabetes and Associated Complications 1-18 (Elsevier, 2024)","DOI":"10.1016\/B978-0-443-13195-0.00001-6"},{"key":"90156_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/0113894501313365240722100902","volume":"25","author":"F Khan","year":"2024","unstructured":"Khan, F., Khan, M. V., Kumar, A. & Akhtar, S. Recent Advances in the Development of Alpha-Glucosidase and Alpha-Amylase Inhibitors in Type 2 Diabetes Management: Insights from In silico to In vitro Studies. Curr. Drug Targets 25, 782\u2013795 (2024).","journal-title":"Curr. Drug Targets"},{"key":"90156_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/biom11111692","volume":"11","author":"AM Udrea","year":"2021","unstructured":"Udrea, A. M. et al. Advanced bioinformatics tools in the pharmacokinetic profiles of natural and synthetic compounds with anti-diabetic activity. Biomolecules 11, 1692 (2021).","journal-title":"Biomolecules"},{"key":"90156_CR10","doi-asserted-by":"crossref","unstructured":"Bhatnagar, A. Mishra, A. In Natural products as enzyme inhibitors: An industrial perspective 269-283 (Springer 2022).","DOI":"10.1007\/978-981-19-0932-0_12"},{"key":"90156_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202103848","volume":"7","author":"VM Patil","year":"2022","unstructured":"Patil, V. M., Tilekar, K. N., Upadhyay, N. M. & Ramaa, C. Synthesis, in-vitro evaluation and molecular docking study of N-substituted thiazolidinediones as \u03b1-glucosidase inhibitors. ChemistrySelect 7, e202103848 (2022).","journal-title":"ChemistrySelect"},{"key":"90156_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105073","volume":"114","author":"LM Aroua","year":"2021","unstructured":"Aroua, L. M. et al. A facile approach synthesis of benzoylaryl benzimidazole as potential \u03b1-amylase and \u03b1-glucosidase inhibitor with antioxidant activity. Bioorganic chem. 114, 105073 (2021).","journal-title":"Bioorganic chem."},{"issue":"46","key":"90156_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040412","volume":"130","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et. al. Exploring the causal relationships between type 2 diabetes and neurological disorders using a Mendelian randomization strategy. Medicine 103(46), e40412. https:\/\/doi.org\/10.1097\/MD.0000000000040412 (2024).","journal-title":"Medicine"},{"key":"90156_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.128532","volume":"1218","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. In silico study reveals existing drugs as \u03b1-glucosidase inhibitors: Structure-based virtual screening validated by experimental investigation. J. Mol. Struct. 1218, 128532 (2020).","journal-title":"J. Mol. Struct."},{"key":"90156_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202300241","volume":"8","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., Taslimi, P., Sadeghian, N., Taskin-Tok, T. & G\u00fcl\u00e7in, \u0130. Synthesis, characterization, bioactivity impacts of new anthranilic acid hydrazones containing aryl sulfonate moiety as fenamate isosteres. ChemistrySelect 8, e202300241 (2023).","journal-title":"ChemistrySelect"},{"key":"90156_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202204019","volume":"7","author":"F Sinan Tokal\u0131","year":"2022","unstructured":"Sinan Tokal\u0131, F. Novel Benzoic acid derivatives bearing quinazolin-4 (3H)-one ring: synthesis, characterization, and inhibition effects on \u03b1-glucosidase and \u03b1-amylase. ChemistrySelect 7, e202204019 (2022).","journal-title":"ChemistrySelect"},{"key":"90156_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23521","volume":"38","author":"FS Tokal\u0131","year":"2024","unstructured":"Tokal\u0131, F. S. et al. Novel hydrazones derived from anthranilic acid as potent cholinesterases and \u03b1-glycosidase inhibitors: Synthesis, characterization, and biological effects. J. Biochem. & Mol. Toxicol. 38, e23521 (2024).","journal-title":"J. Biochem. & Mol. Toxicol."},{"key":"90156_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202301158","volume":"8","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., Taslimi, P., Sadeghi, M. & \u015eenol, H. Synthesis and evaluation of quinazolin-4 (3H)-one derivatives as multitarget metabolic enzyme inhibitors: A biochemistry-oriented drug design. ChemistrySelect 8, e202301158 (2023).","journal-title":"ChemistrySelect"},{"key":"90156_CR19","doi-asserted-by":"publisher","first-page":"2000455","DOI":"10.1002\/ardp.202000455","volume":"354","author":"FS Tokal\u0131","year":"2021","unstructured":"Tokal\u0131, F. S. et al. Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives. Archiv. der. Pharm. 354, 2000455 (2021).","journal-title":"Archiv. der. Pharm."},{"key":"90156_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jep.2016.07.024","volume":"192","author":"B Dai","year":"2016","unstructured":"Dai, B. et. al. The effect of Liuwei Dihuang decoction on PI3K\/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance. J. Ethnopharmacol. 192, 382\u2013389. https:\/\/doi.org\/10.1016\/j.jep.2016.07.024 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"90156_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202301134","volume":"20","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S. et al. Novel quinazolinone derivatives: potential synthetic analogs for the treatment of glaucoma, alzheimer\u2019s disease and diabetes mellitus. Chemi. & biodiverse. 20, e202301134 (2023).","journal-title":"Chemi. & biodiverse."},{"key":"90156_CR22","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.240543","volume":"11","author":"A Sardar","year":"2024","unstructured":"Sardar, A. et al. Synthesis and biological evaluation of diclofenac acid derivatives as potential lipoxygenase and \u03b1-glucosidase inhibitors. R. Soc. Open Sci. 11, 240543 (2024).","journal-title":"R. Soc. Open Sci."},{"key":"90156_CR23","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.3390\/ijms23158117","volume":"23","author":"O Ebenezer","year":"2022","unstructured":"Ebenezer, O. et al. An overview of the biological evaluation of selected nitrogen-containing heterocycle medicinal chemistry compounds. Int. J. Mol. Sci. 23, 8117 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"90156_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129531","volume":"1227","author":"AA Mohammadi","year":"2021","unstructured":"Mohammadi, A. A. et al. Synthesis of the new tri-amide derivatives as novel \u03b1-glucosidase inhibitors by Ugi four-component reaction. J. Mol. Struct. 1227, 129531 (2021).","journal-title":"J. Mol. Struct."},{"key":"90156_CR25","doi-asserted-by":"publisher","first-page":"10030","DOI":"10.1038\/s41598-023-36890-y","volume":"13","author":"M Emadi","year":"2023","unstructured":"Emadi, M. et al. Design, synthesis, in vitro anti-\u03b1-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1, 2, 3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents. Sci. Rep. 13, 10030 (2023).","journal-title":"Sci. Rep."},{"key":"90156_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22128","volume":"85","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Discovery of N-(phenylsulfonyl) thiazole-2-carboxamides as potent \u03b1-glucosidase inhibitors. Drug Dev. Res. 85, e22128 (2024).","journal-title":"Drug Dev. Res."},{"issue":"20","key":"90156_CR27","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/0113816128302667240422110226","volume":"30","author":"J Liang","year":"2024","unstructured":"Liang, J. et. al. The Regulation of Selenoproteins in Diabetes: A New Way to Treat Diabetes. Curr. Pharm. Des. 30(20), 1541\u20131547. https:\/\/doi.org\/10.2174\/0113816128302667240422110226 (2024).","journal-title":"Curr. Pharm. Des."},{"key":"90156_CR28","doi-asserted-by":"publisher","first-page":"2300423","DOI":"10.1002\/ardp.202300423","volume":"356","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Yetke, H. \u0130 & Hac\u0131osmano\u011flu-Aldo\u011fan, E. Novel quinazoline\u2013chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies. Archiv. der. Pharm. 356, 2300423 (2023).","journal-title":"Archiv. der. Pharm."},{"key":"90156_CR29","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1021\/acschemneuro.3c00393","volume":"14","author":"A Singh","year":"2023","unstructured":"Singh, A. et al. Pathogenesis of alzheimer\u2019s disease and diversity of 1, 2, 3-triazole scaffold in drug development: design strategies, structural insights, and therapeutic potential. ACS chem. Neurosci. 14, 3291\u20133317 (2023).","journal-title":"ACS chem. Neurosci."},{"key":"90156_CR30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ph16091310","volume":"16","author":"RS Ipe","year":"2023","unstructured":"Ipe, R. S. et al. A concise review of the recent structural explorations of chromones as MAO-B inhibitors: Update from 2017 to 2023. Pharmaceuticals 16, 1310 (2023).","journal-title":"Pharmaceuticals"},{"key":"90156_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2174\/0115734064293848240408085039","volume":"20","author":"R Gawali","year":"2024","unstructured":"Gawali, R., Bhosale, R., Bavi, R., Jadhav, S. & Peerzade, N. Synthesis, Molecular docking studies and biological evaluation of thiazolyl hydrazone derivatives of chromone-3-carbaldehyde as potent anti-oxidant and anti-inflammatory agents. Med. Chem. 20, 818\u2013830 (2024).","journal-title":"Med. Chem."},{"key":"90156_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105591","volume":"120","author":"EK Abdelall","year":"2022","unstructured":"Abdelall, E. K., Elshemy, H. A., Labib, M. B. & Mohamed, F. E. Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual \u03b2-tubulin\/c-Src inhibition, cell cycle arrest and apoptosis induction. Bioorgan. Chem. 120, 105591 (2022).","journal-title":"Bioorgan. Chem."},{"key":"90156_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136647","volume":"1295","author":"YK Al-Majedy","year":"2024","unstructured":"Al-Majedy, Y. K. et al. Synthesis, biomedical activities, and molecular docking study of novel chromone derivatives. J. Mol. Struct. 1295, 136647 (2024).","journal-title":"J. Mol. Struct."},{"key":"90156_CR34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11030-020-10060-y","volume":"25","author":"S Shaikh","year":"2021","unstructured":"Shaikh, S., Dhavan, P., Ramana, M. & Jadhav, B. Design, synthesis and evaluation of new chromone-derived aminophosphonates as potential acetylcholinesterase inhibitor. Mol. Divers. 25, 811\u2013825 (2021).","journal-title":"Mol. Divers."},{"key":"90156_CR35","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/j.bmcl.2017.05.007","volume":"27","author":"G Wang","year":"2017","unstructured":"Wang, G. et al. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as \u03b1-glucosidase inhibitors. Bioorgan. & Med. Chem. Lett. 27, 2957\u20132961 (2017).","journal-title":"Bioorgan. & Med. Chem. Lett."},{"key":"90156_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.134575","volume":"1274","author":"M Fan","year":"2023","unstructured":"Fan, M., Zhong, X., Huang, Y., Peng, Z. & Wang, G. Synthesis, biological evaluation and molecular docking studies of chromone derivatives as potential \u03b1-glucosidase inhibitors. J. Mol. Struct. 1274, 134575 (2023).","journal-title":"J. Mol. Struct."},{"issue":"4","key":"90156_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","volume":"22","author":"L Kang","year":"2018","unstructured":"Kang, L. et. al. Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol. Divers. 22(4), 893\u2013906. https:\/\/doi.org\/10.1007\/s11030-018-9839-y (2018).","journal-title":"Mol. Divers."},{"issue":"8","key":"90156_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ddr.21726","volume":"81","author":"Q Lu","year":"2020","unstructured":"Lu, Q. et. al. Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Dev. Res. 81(8), 1037\u20131047. https:\/\/doi.org\/10.1002\/ddr.21726 (2020).","journal-title":"Drug Dev. Res."},{"key":"90156_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140109","author":"B Atasever-Arslan","year":"2025","unstructured":"Atasever-Arslan, B., Kaya, B., \u015eahin, O. & \u00dclk\u00fcseven, B. A square planar cobalt (II)-thiosemicarbazone complex Synthesis, characterization, antiviral and anti-inflammatory potential. J. Mol. Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140109 (2025).","journal-title":"J. Mol. Struct."},{"key":"90156_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140406","volume":"1322","author":"H Mu\u011flu","year":"2025","unstructured":"Mu\u011flu, H. Synthesis, spectroscopic characterization, DFT studies and antioxidant activity of new 5-substituted isatin\/thiosemicarbazones. J. Mol. Struct. 1322, 140406 (2025).","journal-title":"J. Mol. Struct."},{"key":"90156_CR41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s11696-023-03214-3","volume":"78","author":"MJC da Silva","year":"2024","unstructured":"da Silva, M. J. C. et al. Synthesis of trimethoxy-benzylidene-hydrazine-carboxamide compounds: antioxidant, antimicrobial and antiparasitic agent, evaluation of the interaction with BSA and ADMET parameters. Chem. Pap. 78, 1897\u20131913 (2024).","journal-title":"Chem. Pap."},{"key":"90156_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140764","author":"V Singh","year":"2024","unstructured":"Singh, V., Haribabu, J., Moraga, D., Santibanez, J. F. & Sreekanth, A. Investigation of the anticancer potential of newly synthesized N4-substituted thiosemicarbazones: In silico and in vitro biological approaches. J. Mol. Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140764 (2024).","journal-title":"J. Mol. Struct."},{"key":"90156_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138671","volume":"1312","author":"S Gul","year":"2024","unstructured":"Gul, S. et al. Discovering the anti-diabetic potential of thiosemicarbazone derivatives: In vitro \u03b1-glucosidase, \u03b1-amylase inhibitory activities with molecular docking and DFT investigations. J. Mol. Struct. 1312, 138671 (2024).","journal-title":"J. Mol. Struct."},{"key":"90156_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129666","volume":"1231","author":"FS Tokal\u0131","year":"2021","unstructured":"Tokal\u0131, F. S., Taslimi, P., Usanmaz, H., Karaman, M. & \u015eendil, K. Synthesis, characterization, biological activity and molecular docking studies of novel schiff bases derived from thiosemicarbazide: Biochemical and computational approach. J. mol. Struct. 1231, 129666 (2021).","journal-title":"J. mol. Struct."},{"key":"90156_CR45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/jhet.4619","volume":"60","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Katmerlikaya, T. G., Da\u011f, A. & \u015eendil, K. Novel thiosemicarbazone and thiazolidin-4-one derivatives containing vanillin core: Synthesis, characterization, and anticancer activity studies. J. Heterocycl. Chem. 60, 645\u2013656 (2023).","journal-title":"J. Heterocycl. Chem."},{"key":"90156_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107642","volume":"97","author":"Z Bakherad","year":"2022","unstructured":"Bakherad, Z. et al. In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent \u03b1-glycosidase inhibitors. Comput. Biol. & Chem. 97, 107642 (2022).","journal-title":"Comput. Biol. & Chem."},{"key":"90156_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11030-018-9835-2","volume":"22","author":"M Ali","year":"2018","unstructured":"Ali, M. et al. Synthesis, in vitro \u03b1 \u03b1-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene) hydrazinyl)-4-arylthiazole derivatives. Mol. Divers. 22, 841\u2013861 (2018).","journal-title":"Mol. Divers."},{"key":"90156_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106739","volume":"139","author":"R Basri","year":"2023","unstructured":"Basri, R. et al. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as \u03b1-glucosidase inhibitors. Bioorgan. Chem. 139, 106739 (2023).","journal-title":"Bioorgan. Chem."},{"key":"90156_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ddr.22031","volume":"84","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., Demir, Y., T\u00fcrke\u015f, C., Din\u00e7er, B. & Beydemir, \u015e. Novel acetic acid derivatives containing quinazolin-4 (3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Dev. Res. 84, 275\u2013295 (2023).","journal-title":"Drug Dev. Res."},{"key":"90156_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202300773","volume":"20","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H., \u00c7a\u011fman, Z., Gen\u00e7o\u011flu Katmerlikaya, T. & Sinan Tokal\u0131, F. New Anthranilic acid hydrazones as fenamate isosteres: synthesis, characterization, molecular docking, dynamics & in silico adme, in vitro anti-inflammatory and anticancer activity studies. Chem. & biodivers. 20, e202300773 (2023).","journal-title":"Chem. & biodivers."},{"key":"90156_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.135176","volume":"1282","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Bulut, \u015e & Hac\u0131osmano\u011flu-Aldo\u011fan, E. Synthesis, characterization and molecular docking studies of highly selective new hydrazone derivatives of anthranilic acid and their ring closure analogue Quinazolin-4 (3H)-ones against lung cancer cells A549. J. Mol. Struct. 1282, 135176 (2023).","journal-title":"J. Mol. Struct."},{"key":"90156_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139519","volume":"1319","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Ate\u015fo\u011flu, \u015e, Tokal\u0131, P. & Akba\u015f, F. Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies. J. Mol. Struct. 1319, 139519 (2025).","journal-title":"J. Mol. Struct."},{"key":"90156_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.141374","author":"KA Dahlous","year":"2025","unstructured":"Dahlous, K. A. et al. Design, synthesis, in-vitro and in-silico studies of 6-bromochromone based thiosemicarbazones as \u03b1-glucosidase inhibitors. J. Mol. Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2025.141374 (2025).","journal-title":"J. Mol. Struct."},{"key":"90156_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106384","volume":"132","author":"M Fan","year":"2023","unstructured":"Fan, M. et al. Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting \u03b1-glucosidase. Bioorgan. Chem. 132, 106384 (2023).","journal-title":"Bioorgan. Chem."},{"key":"90156_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2024.100694","volume":"9","author":"SR Jadhav","year":"2024","unstructured":"Jadhav, S. R., Gurav, S. S., Yasin, H., Nagpal, P. & Mali, S. N. Imidazo [1, 2-a] pyridine-appended chalcone and Schiff base conjugates: Synthetic, spectrophotometric, biological, and computational aspects. Chem. Phys. Impact 9, 100694 (2024).","journal-title":"Chem. Phys. Impact"},{"key":"90156_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1142\/S2737416523500655","volume":"23","author":"AR Chopade","year":"2024","unstructured":"Chopade, A. R. et al. Antifibromyalgic Activity of phytomolecule niranthin: In-vivo analysis, molecular docking, dynamics and dfT. J. Comput. Biophys. & Chem. 23, 333\u2013348 (2024).","journal-title":"J. Comput. Biophys. & Chem."},{"key":"90156_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. comput. Chem."},{"key":"90156_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400140","author":"RD Alharthy","year":"2024","unstructured":"Alharthy, R. D. et al. Synthesis of the chromone-thiosemicarbazone scaffold as promising \u03b1-glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design. Archiv. der. Pharmazie https:\/\/doi.org\/10.1002\/ardp.202400140 (2024).","journal-title":"Archiv. der. Pharmazie"},{"key":"90156_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2024.100494","volume":"8","author":"SS Gurav","year":"2024","unstructured":"Gurav, S. S. et al. New 2-Chloroimidazo [1, 2-a] pyridine induced Schiff bases: Synthesis, characterization, antimicrobial and A-498 and A-549 anticancer activity, molecular modeling, in-silico pharmacokinetics, and DFT studies. Chem. Phys. Impact 8, 100494 (2024).","journal-title":"Chem. Phys. Impact"},{"key":"90156_CR60","doi-asserted-by":"publisher","first-page":"2403608","DOI":"10.1080\/17518253.2024.2403608","volume":"17","author":"OA Lotlikar","year":"2024","unstructured":"Lotlikar, O. A. et al. Microwave and ultrasound-assisted green protocols for 5-methylthiazole induced Betti bases: molecular docking, in-silico pharmacokinetics, and anticancer activity studies. Green Chem. Lett. & Rev. 17, 2403608 (2024).","journal-title":"Green Chem. Lett. & Rev."},{"key":"90156_CR61","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. rep. 7, 42717 (2017).","journal-title":"Sci. rep."},{"key":"90156_CR62","doi-asserted-by":"publisher","first-page":"25754","DOI":"10.1038\/s41598-024-75100-1","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. Sci. Rep. 14, 25754 (2024).","journal-title":"Sci. Rep."},{"key":"90156_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2024.100713","volume":"9","author":"N Kumar","year":"2024","unstructured":"Kumar, N., Yasin, H., Sharma, S., Mali, S. N. & Gurav, S. S. Studies on chlorophenyl, thiophenyl, and biphenyl clubbed tetrahydro bipyrazole carbaldehydes: Synthesis, antimicrobial and antioxidant activity, SAR study, in-silico pharmacokinetics, toxicity, and molecular modeling. Chem. Phys. Impact 9, 100713 (2024).","journal-title":"Chem. Phys. Impact"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90156-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:10:11Z","timestamp":1742775011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90156-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90156"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90156-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9816"}}